SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $394,000 | -17.1% | 2,132,000 | 0.0% | 0.12% | +27.7% |
| Q1 2022 | $475,000 | -45.7% | 2,132,000 | 0.0% | 0.09% | -24.2% |
| Q4 2021 | $874,000 | -55.7% | 2,132,000 | 0.0% | 0.12% | -49.4% |
| Q3 2021 | $1,971,000 | -18.9% | 2,132,000 | 0.0% | 0.24% | -26.9% |
| Q2 2021 | $2,430,000 | -9.5% | 2,132,000 | 0.0% | 0.34% | -16.7% |
| Q1 2021 | $2,686,000 | -62.1% | 2,132,000 | -41.9% | 0.40% | -54.7% |
| Q4 2020 | $7,084,000 | -23.1% | 3,670,384 | 0.0% | 0.89% | -26.9% |
| Q3 2020 | $9,213,000 | +13.1% | 3,670,384 | 0.0% | 1.21% | +17.4% |
| Q2 2020 | $8,148,000 | -11.6% | 3,670,384 | -5.2% | 1.03% | -62.2% |
| Q1 2020 | $9,212,000 | -19.1% | 3,870,627 | 0.0% | 2.74% | +28.1% |
| Q4 2019 | $11,380,000 | +96.0% | 3,870,627 | 0.0% | 2.14% | +49.6% |
| Q3 2019 | $5,806,000 | -45.6% | 3,870,627 | +1.5% | 1.43% | -37.8% |
| Q2 2019 | $10,678,000 | +35.9% | 3,813,558 | 0.0% | 2.30% | +37.4% |
| Q1 2019 | $7,856,000 | +24.7% | 3,813,558 | +3.5% | 1.67% | -14.4% |
| Q4 2018 | $6,298,000 | +19.6% | 3,683,195 | +51.1% | 1.95% | +69.4% |
| Q3 2018 | $5,266,000 | -7.7% | 2,438,060 | 0.0% | 1.15% | -16.4% |
| Q2 2018 | $5,705,000 | +31.8% | 2,438,060 | +2.1% | 1.38% | +31.5% |
| Q1 2018 | $4,330,000 | +0.7% | 2,388,060 | 0.0% | 1.05% | +22.8% |
| Q4 2017 | $4,299,000 | – | 2,388,060 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|